Immunization Information for Providers
- Immunization Requirements for School and Child Care: 2020-2021
- Recommended Immunization Schedules, United States
- Guide to Vaccine Contraindications and Precautions
- Vaccines Recommendations for People with Specific Diseases or Conditions
- Immunization of Immunocompromised Persons
- Vaccine Management: Recommendations for Handling and Storage of Selected Biologicals
- Other NYC DOHMH Publications
- NYS Seasonal Influenza Information
Influenza and Pneumococcal Information
- Encourage Your Patients to Get the Flu Vaccine Visual Abstract (PDF)
- Requirements for flu vaccination (or wearing mask for duration of flu season) for Article 28 facilities
- City Health Information: Influenza Prevention and Control, 2019–2020 (PDF)
- Influenza and Pneumococcal Vaccine Ordering and Immunization Billing Code Information 2019-20 (PDF)
- Morbidity and Mortality Weekly Report — Prevention and Control of Influenza with Vaccine, 2019-20
- Standing Order and Protocol for Vaccinations — Template (PDF)
- Refusal to Receive Vaccination Form (PDF)
- FluView Weekly CDC Report
- Seasonal Flu Main Page
Perinatal Hepatitis B Prevention Program
The program identifies pregnant people with hepatitis B, conducts case management of infants at risk for perinatal hepatitis B infection, and works with hospitals to achieve universal birth dose coverage and documentation of the birth dose in the Citywide Immunization Registry.
- Reporting instructions for hepatitis B in pregnancy or post-partum/delivery
- Provider resources for perinatal hepatitis B prevention
- Patient information for hepatitis B and pregnancy
Letters to Providers
2025
- Nirsevimab (Beyfortus) Online Ordering Deadline for VFC Program (PDF, February 28)
- Update on Influenza and RSV Activity and Prevention (PDF, February 12)
2024
- Update on Influenza and RSV Activity and Prevention (PDF, December 9)
- Abrysvo Administration and Reporting in Pregnancy (PDF, December 4)
- Respiratory Virus Season Preparation (PDF, November 13)
- 2024-2025 COVID-19 Vaccines Update (PDF, September 5)
- Nirsevimab: Clinical Guidance and VFC Ordering (PDF, September 3)
- 2024-2025 Seasonal Flu Vaccination Kick-Off Letter and VFC Flu Vaccine Ordering (PDF, August 28)
- Update for 2024-2025 Formulation of COVID-19 Vaccines (PDF, June 24)
- COVID-19 Vaccine Updates for Providers (PDF, June 18)
- 2023-2024 COVID-19 Vaccine Availability Update (PDF, April 29)
- Immunization Provider Honor Roll Award Recipients for 2024 (PDF, April 24)
- Additional Dose of COVID-19 Vaccine for People 65 Years of Age and Older (PDF, March 1)
- Strategies to Increase Pediatric Immunization in NYC (PDF, February 28)
- NYC Health Department Frequently Asked Immunization Questions (PDF, February 12)
- Update on Influenza and RSV Activity and Prevention (PDF, February 6)
- Update on VFC Supply and Recommendations for Use of Nirsevimab (PDF, January 16)
2023
- Update on Influenza and RSV Activity and Prevention (PDF, December 19)
- Ensuring Correct Dosing of Moderna COVID-19 Vaccine for Children (PDF, November 6)
- 2023-2024 VFC Re-enrollment Open Now (PDF, November 2)
- VFC Policy Updates (PDF, October 30)
- Update on Influenza Activity and Flu Vaccine Availability (PDF, October 25)
- Updated Novavax COVID-19 Vaccine Available to Order (PDF, October 17)
- New Immunization Products to Prevent RSV (PDF, October 10)
- NYC Vaccines for Adults (VFA) Program Enrollment Is Open (PDF, October 10)
- Update Your Influenza Vaccine Codes 2023-2024 (PDF, September 12)
- Updated COVID-19 Vaccines Available for VFC Ordering in CIR (PDF, September 11)
- 2023-2024 Seasonal Flu Vaccination Kick-Off Letter and VFC Flu Vaccine Ordering (PDF, September 7)
- What to Expect with Commercialization of COVID-19 Vaccines (PDF, August 29)
- New Menveo Formulation and New Childhood Indication for PCV-20 (PDF, August 22)
- COVID-19 Vaccination Updates (PDF, July 21)
- COVID-19 Vaccination Updates (PDF, May 9)
- COVID-19 Vaccination Updates (PDF, April 21)
- Mpox Updates for NYC Providers (PDF, April 12)
- Update on Influenza Activity and Flu Vaccine Availability (PDF, April 11)
- Updated COVID-19 Booster Eligibility for Children 6 Months - 4 Years (PDF, March 24)
- 2023 Recommended Immunization Schedules Now Available and Updates to Decision Support in the CIR (PDF, March 9)
- Update on Influenza Activity and Flu Vaccine Availability (PDF, February 28)
- Update on Influenza Activity and Flu Vaccine Availability (PDF, January 24)
2022
- Update on Influenza Activity and Flu Vaccine Availability (PDF, December 23)
- Two New Vaccines Are Available Through VFC: PRIORIX (MMR) and VAXNEUVANCE (PCV15) (PDF, December 13)
- Update on Influenza Activity and Flu Vaccine Availability (PDF, November 16)
- Vaccines for Children (VFC) Program Updates (PDF, November 10)
- CORRECTION: Novavax COVID-19 Boosters Allowed for People Ages 18 Years and Older (PDF, November 1)
- CDC Expands Bivalent COVID-19 Booster Recommendation to Include Children Ages 5 to 11 Years (PDF, October 14)
- Update on Influenza Activity and Flu Vaccine Availability (PDF, September 22)
- Notice: Update Your Influenza Vaccine Codes 2022-2023 (PDF, September 9)
- CDC Recommends Bivalent COVID-19 Boosters for Everyone Ages 12 Years and Older (PDF, September 6)
- Back-to-School Immunization Requirements (PDF, August 29)
- 2022-2023 Seasonal Influenza Vaccination Kick-Off Letter and VFC Flu Vaccine Ordering (PDF, August 23)
- NYC Health Alert #20: Update on Poliovirus in New York City (PDF, August 12)
- Moderna COVID-19 Vaccine for Children Ages 6 to 17 Years (PDF, June 29)
- CDC Expands Recommendation for COVID-19 Vaccination to Children Ages 6 Months to 5 Years (PDF, July 21)
- Update on COVID-19 Booster Doses (PDF, May 20)
- New Recommendations for Universal Hepatitis B Vaccination for Adults (PDF, April 25)
- CDC Allows Second COVID-19 Boosters for Certain People (PDF, March 31)
- Update on Influenza Activity (PDF, March 15)
- 2022 Recommended Child/Adolescent and Adult Immunization Schedules Now Available (PDF, March 1)
- Updates to CDC COVID-19 Vaccine Guidance, Including For People Who Are Immunocompromised (PDF, February 17)
- Update on Influenza Activity (PDF, February 10)
- Ordering COVID-19 Vaccine for Children 6 Months to 4 Years (PDF, February 9)
- Note: On February 12, the FDA postponed its meeting to review COVID-19 vaccine for children ages 6 months to 4 years. This was done to provide additional time for the FDA to review data submitted by Pfizer related to its emergency use authorization request for the use of its vaccine for this age group.
- Incorporating COVID-19 Vaccination into Pediatric Primary Care (PDF, February 4)
- Moderna Booster Interval Shortened to Five Months (PDF, January 10)
- Update on Influenza Activity and Flu Vaccine Availability (PDF, January 9)
- CDC COVID-19 Vaccine Updates (PDF, January 6)
2021
- Pfizer Orange Cap (pediatric) and Pfizer Gray Cap (12+) Shelf-Life Extensions (PDF, December 21)
- mRNA COVID-19 Vaccines Preferred Over Johnson & Johnson (PDF, December 21)
- COVID-19 Boosters Recommended for People Ages 16 and 17 Years (PDF, December 16)
- New Pfizer COVID-19 Vaccine Formulation (PDF, December 15)
- Preventing COVID-19 Vaccine Errors (PDF, December 7)
- Update on Influenza Activity and Flu Vaccine Availability (PDF, December 6)
- CDC Recommends All Adults May Receive a COVID-19 Booster Dose (PDF, November 23)
- Advisory for Health Care Providers to Offer Booster Doses of COVID-19 Vaccine (PDF, November 17)
- New ACIP Recommendations for Zoster, Pneumococcal and Hep B Vaccines (PDF, November 15)
- Update on COVID-19 Vaccine Booster Doses (PDF, November 12)
- CDC Recommends Pfizer COVID-19 Vaccine for Children Ages 5 to 11 Years (PDF, November 4)
- Update on Influenza Activity and Flu Vaccine Availability (PDF, November 2)
- Pfizer COVID-19 Vaccine Recommended for FDA Authorization for Children Ages 5 to 11 (PDF, October 29)
- Letter to Providers: CDC Recommends COVID-19 Vaccine Boosters for Johnson & Johnson and Moderna Recipients (PDF, October 22)
- Importance of Race and Ethnicity Data for COVID-19 Vaccine Reporting (PDF, October 21)
- Pre-Order Pfizer Vaccine for Children 5 to 11 (PDF, October 18)
- COVID-19 Vaccination for People With Prior SARS-CoV-2 Infection (PDF, October 4)
- CDC Recommends Pfizer COVID-19 Booster Dose for Some Adults (PDF, September 27)
- Update on Influenza Activity and Flu Vaccine Availability (PDF, September 24)
- ACIP Recommends Use of Pfizer COVID-19 Vaccine (PDF, August 31)
- FDA Approves Pfizer COVID-19 Vaccine and Extends Expiration Dates (PDF, August 24)
- 2021-2022 Seasonal Influenza Vaccination Kick-Off Letter and VFC Flu Vaccine Ordering (PDF, August 20)
- Letter to Providers: Additional mRNA Dose for People Who Are Immunocompromised (PDF, August 16)
- Youth Vaccination: Help Increase Adolescent COVID-19 Vaccination (PDF, August 10)
- Declining Childhood Immunization and Back to School Immunization Requirements (PDF, July 23)
- Safeguard Your Vaccines During the Summer (PDF, July 20)
- Two New Vaccines are Available: MenQuadfi (MenACWY) and VAXELIS (DTaP, IPV, Hib, HepB) (PDF, June 7)
- 2021 Recommended Children/Adolescent and Adult Immunization Schedules Now Available (PDF, February 26)
Vaccine Information Statements
Under the National Childhood Vaccine Injury Act, all health care providers are required to use Vaccine Information Statements to inform parents, guardians, legal representatives and adult patients about the benefits and risks of vaccines prior to vaccination. You can find a complete list of Vaccine Information Statements in many languages at Immunization Action Coalition.
Lifetime Health Records
The Lifetime Health Record can only be ordered by providers giving healthcare to children. To order the Lifetime Health Record, call the Health Department Call Center at (917) 438-9766. Parents who need to replace a lost record should contact their child's provider.
Immunization Information for Health Care Providers
- Vaccinations for School and Day Care
- Learn about the Vaccines for Children Program
- Citywide Immunization Registry – For Providers
- Learn about the new Adult Immunization Standards
- Read about Reporting Vaccine-Preventable Diseases
- Report adverse reactions to the federal Vaccine Adverse Event Reporting System (VAERS)
- See Recent Health Alerts and Advisories
- Citywide Immunization Registry – For Providers
- Adult Immunization Action Kit
- HPV Vaccine Action Kit
- Vaccination Information for Pharmacists